Report to PCWP/HCPWP from HMPC Herbal monographs, consultation of - PowerPoint PPT Presentation

Report to PCWP/HCPWP from HMPC Herbal monographs, consultation of patients and possible training sessions Steffen Bager, HMPC member Classified as public by the European Medicines Agency

Consulting patients on herbal medicinal products ‒ Already established consultation of ARSP’s ‒ Commenting draft monographs in December 2019: • Rheum palmatum • Rhamnus purshiana • Thyme oil • Tanacetum parthenium 2 5. MARTS 2020 Classified as public by the European Medicines Agency

Early experiences – how to increase involvement / knowledge ‒ Continue with the regular practice to consult patient representatives on draft HMPC documents (e.g. Herbal summaries for the public, draft monographs) ‒ Organise information session to raise understanding of different document functions (e.g. MO, AR, vs SmPC and labelling) – including the role of patients input ‒ Consult patient representatives for specific questions via EMA established network of patients, via PCWP/HCPWP ‒ Call for additional members to join ‘ herbal patient group ’ 3 5. MARTS 2020 Classified as public by the European Medicines Agency

Følg os 4 5. MARTS 2020 Classified as public by the European Medicines Agency